分次放疗对脊柱骨转移瘤稳定性的影响:一项1047例回顾性分析
该回顾性研究纳入2000至2015年间在本院接受姑息性放疗的1047例溶骨性脊柱骨转移患者,比较5x4Gy、10x3Gy、14×2.5Gy和20x2Gy等不同多分次方案在放疗后3个月和6个月的影像学反应与再钙化。结果显示短程与长程放疗组在获得再钙化的稳定率方面无显著差异,两组在放疗后3个月和6个月均显示出稳定效果。
要点
- 短程放疗组放疗后3个月和6个月不稳定脊柱骨转移的稳定率分别为17.6%和31.1%。
- 长程放疗组放疗后3个月和6个月不稳定脊柱骨转移的稳定率分别为24.1%和34.2%。
- 多分次方案短程与长程放疗在实现再钙化的稳定率方面无显著差异。
核心结论
- 本研究表明,在姑息性治疗不稳定脊柱骨转移时,多分次方案短程放疗与长程放疗在实现再钙化的稳定率方面无显著差异。
- 两组多分次方案在放疗后3个月和6个月均显示出稳定效果。
研究设计与样本
- 回顾性评估2000年至2015年间在本院接受姑息性放疗的1047例溶骨性脊柱骨转移患者。
- 最常见的实体瘤为肺癌(40.2%)、乳腺癌(16.7%)和肾癌(15.2%)。
- 比较5x4Gy、10x3Gy、14×2.5Gy和20x2Gy等不同常用多分次方案在放疗后3个月和6个月的影像学反应与再钙化。
- 采用Taneichi评分对溶骨性脊柱骨转移进行分类。
主要发现
- 中位随访时间为6.3个月。
- 使用少于10次治疗分次的短程放疗组中位总生存期为5.5个月,使用超过10次分次的长程放疗组为9.5个月(对数秩检验p<.0001)。
- 短程放疗组放疗后3个月和6个月的总生存率分别为66.8%和49.1%,长程放疗组分别为80.9%和61.5%。
- 短程放疗组放疗后3个月和6个月不稳定脊柱骨转移被分类为稳定的比例分别为17.6%(n=54/306)和31.1%(n=89/286)(两者p<.001)。
- 长程放疗组放疗后3个月和6个月不稳定脊柱骨转移获得稳定的比例分别为24.1%(n=28/116)和34.2%(n=38/111)(两者p<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of radiotherapy, in particular the application of different multi-fraction schedules in the management of unstable spinal bone metastases (SBM), is incompletely understood. This study aims to compare the radiological response regarding various dose and fractionation schedules of radiotherapy in the palliative treatment of SBM. METHODS: We retrospectively assessed 1047 patients with osteolytic SBM, treated with palliative radiotherapy at our department between 2000 and 2015. Lung cancer (40.2%), breast (16.7%) and renal cancer (15.2%) were the most common solid tumors in this study. Different common multi-fraction regimen (5x4Gy, 10x3Gy, 14 × 2.5Gy and 20x2Gy) were compared with regard to radiological response and recalcification at 3 and 6 months after radiotherapy. The Taneichi score was used for classification of osteolytic SBM. RESULTS: Median follow up was 6.3 months. The median overall survival (OS) in the short-course radiotherapy (SCR) group using less than 10 treatment fractions was 5.5 months vs. 9.5 months in the long-course radiotherapy (LCR) group using in excess of 10 fractions (log rank p < .0001). Overall survival (OS) in the SCR group after 3 and 6 months was 66.8 and 49.1%, respectively vs 80.9 and 61.5%, respectively in the LCR group. 17.6% (n = 54/306) and 31.1% (n = 89/286) of unstable SBM were classified as stable in the SCR group at 3 and 6 months post radiotherapy, respectively (p < .001 for both). In the LCR group, 24.1% (n = 28/116) and 34.2% (n = 38/111) of unstable SBM were stabilized after 3 and 6 months, respectively (p < .001 for both). CONCLUSIONS: Our study shows no significant difference in stabilization achieving recalcification rates between multi-fraction schedules (SCR vs. LCR) in the palliative management of unstable SBM. Both groups with multi-fraction regimen demonstrate a stabilizing effect following 3 and 6 months after radiotherapy.
引用
- Sprave T, Hees K, Bruckner T, et al. The influence of fractionated radiotherapy on the stability of spinal bone metastases: a retrospective analysis from 1047 cases. Radiat Oncol. 2018. PMID: 30041672. doi:10.1186/s13014-018-1082-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。